Cetuximab Terminated Phase 2 Trials for Multiple Myeloma (MM) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00368121EMMA-1 (Erbitux for Multiple Myeloma)